The rising need to outsource analytical testing services for decreased manufacturing costs and augmented operational efficiency is a key market growth driver
The global healthcare analytical testing services market size is expected to reach USD 11.9 billion by 2028 at a CAGR of 11.6%, according to a new report by Reports and Data. The global market growth is significantly accelerated by the rising need for outsourcing healthcare analytical testing services, the growing number of contract research organizations, increasing clinical trials being performed worldwide, and the surging adoption of the quality-by-design approach among pharmaceutical companies. Pharmaceutical and biopharmaceutical companies worldwide are outsource healthcare analytical testing services to streamline drug manufacturing processes, ease the end-to-end stages of drug discovery, reduce their capital expenditure, and raise profit margins. Healthcare analytical testing services are also leveraged by these companies to reduce the time required for process validation, facilitate clinical trials and commercial launch of drugs, offer in-depth insights into patient records and hospital management, and improve patient outcomes. The significant rise of the biopharmaceutical sector, augmented focus on employing specialized testing services for biologics and biosimilars, and the growing development of biopharmaceutical drugs and products are further expected to propel the global healthcare analytical testing services market growth in the near future. However, the lack of technical expertise and skills and risks of user data breach associated with healthcare analytical testing services are specific factors expected to restrain the growth of this market in the upcoming years.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3843
The report provides comprehensive assessment of the market covering key elements such as revenue estimations, cost analysis, import/export, production and consumption trends, CAGR, gross margin, and supply & demand patterns. It also sheds light on recent technological developments, product advancements, and research and development activities in the region.
The report examines the key players operating in the market along with their market position, market share, revenue, gross margin, and business strategies. SWOT analysis and Porter’s Five Forces Analysis are used to examine and assess the market and its players. It also covers recent mergers and acquisitions, joint ventures, collaborations, agreements, partnerships, and product launches and brand promotions.
Key companies profiled in the report include:
Almac Group, LabCorp, Merck KGAA, Eurofins Scientific, Element Materials Technology, Syneos Health, WuXi PharmaTech, Pace Analytical, Frontage Labs, Medpace Holdings, Intertek, Source BioScience, PRA Health Sciences, STERIS PLC, LGC Limited, and Charles River Laboratories.
Market Segmentation by Types:
By Type (Revenue, USD Billion; 2018-2028)
• Bioanalytical Testing Services
o Immunogenicity & Neutralizing Antibody Testing
o Cell-based Assays
o Virology Testing
o Pharmacokinetic Testing
o Biomarker Testing
o Others
• Method Development & Validation Services
o Extractable & Leachable Method Development & Validation
o Stability-indicating Method Validation
o Process Impurity Method Development & Validation
o Analytical Standard Characterization
o Cleaning Validation
o Technical Consulting
o Others
• Physical Characterization Services
o Laser Particle Size Analysis
o Thermal Analysis
o Surface Area Analysis
o Image Analysis
o Others
• Batch-release Testing Services
o Dissolution Testing
o Disintegration Testing
o Elemental Impurity Testing
o Hardness Testing
o Friability Testing
o Others
• Raw Material Testing Services
o Complete Compendia Testing
o Heavy Metal Testing
o Container Testing
o Karl Fischer Analysis
o Wet Chemistry Analysis
o Other Raw Material Testing Services
• Environmental Monitoring Services
o Air Testing
o Wastewater/ETP Testing
o Others
• Microbial Testing Services
o Microbial Limit Testing
o Preservative Efficacy Testing
o Endotoxin Testing
o Sterility Testing
o Water Testing
o Others
• Stability Testing
o Formulation Evaluation Stability Testing
o Accelerated Stability Testing
o Drug Substance Stability Testing
o Photostability Testing
o Comparative Stability Testing
o Others
By End-user (Revenue, USD Billion; 2018-2028)
• Pharmaceutical & Biopharmaceutical Companies
• Contract Research Organizations
• Medical Device Companies
Order this Report @ https://www.reportsanddata.com/report-pricing/3843
Regional analysis covers in-depth analysis of analysis of the revenue, market share, and growth rate of the global Healthcare Analytical Testing Services market in each region for the forecast period of 2021-2028. The report covers production and consumption rate, current and emerging trends, import/export, supply and demand, and presence of key players in each region.
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o Italy
o France
o BENELUX
o Rest of Europe
• Asia Pacific
o China
o India
o Japan
o South Korea
o Rest of APAC
• Latin America
o Brazil
o Rest of LATAM
• Middle East & Africa
o Saudi Arabia
o U.A.E.
o South Africa
o Rest of MEA
To know more about the report @ https://www.reportsanddata.com/report-detail/healthcare-analytical-...
Key Highlights of the Report:
• Based on type, the batch-release testing segment is poised to record the highest CAGR over the estimated timeframe. The dissolution testing services sub-segment is therefore expected to emerge as the most dominant, with the largest market share.
• Of the various end-users, the pharmaceutical & biopharmaceutical companies segment is projected to account for the largest market share over the forecast period. The growth of this segment is mainly attributed to the growing demand for healthcare analytical testing services among these companies to facilitate clinical trials, drug discovery, and drug development processes.
• The North America region is predicted to dominate the global healthcare analytical testing services market over the estimated period in terms of revenue. The region is home to several leading pharmaceutical companies, which is a key factor propelling the market growth in this region. Increased investments in healthcare research & development programs further bolsters the North America market growth.
Thank you for reading our report. For further inquiry, please connect with us and our team will make sure the report is customized according to your requirements.
Browse More Reports:
ENT Surgical Navigation Systems Market @ https://www.reportsanddata.com/report-detail/ent-surgical-navigatio...
Surgical Robotics and Navigation Market @ https://www.reportsanddata.com/report-detail/surgical-robotics-and-...
Niacinamide Market @ https://www.reportsanddata.com/report-detail/niacinamide-market
Anatomic Pathology Market @ https://www.reportsanddata.com/report-detail/anatomic-pathology-market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]